These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7911346)

  • 1. [Restriction polymorphism of C-HA-ras-1 locus in bladder tumors].
    Descotes F; Bittard H; Bittard M; Adessi GL
    Bull Cancer; 1993 Aug; 80(8):653-8. PubMed ID: 7911346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing.
    Knowles MA; Williamson M
    Cancer Res; 1993 Jan; 53(1):133-9. PubMed ID: 8093230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.
    Ishikawa J; Maeda S; Kamidono S; Sugiyama T
    Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.
    Harada K; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2005 Mar; 12(3):250-5. PubMed ID: 15828951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific H-Ras minisatellite alleles in breast cancer susceptibility.
    Gosse-Brun S; Sauvaigo S; Daver A; Page M; Lortholary A; Larra F; Bignon YJ; Bernard-Gallon D
    Anticancer Res; 1999; 19(6B):5191-6. PubMed ID: 10697533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Loss of Ha-ras alleles in DNA from gastric carcinoma tissue of Chinese individuals].
    Shan X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):171-5. PubMed ID: 1678994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of RAS gene family in specimens of bladder cancer.
    Karimianpour N; Mousavi-Shafaei P; Ziaee AA; Akbari MT; Pourmand G; Abedi A; Ahmadi A; Afshin Alavi H
    Urol J; 2008; 5(4):237-42. PubMed ID: 19101897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?
    Hong SK; Kwak C; Jeon HG; Lee E; Lee SE
    Urology; 2005 Apr; 65(4):697-702. PubMed ID: 15833511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
    Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
    Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.
    Austrup F; Uciechowski P; Eder C; Böckmann B; Suchy B; Driesel G; Jäckel S; Kusiak I; Grill HJ; Giesing M
    Br J Cancer; 2000 Dec; 83(12):1664-73. PubMed ID: 11104564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between H-ras minisatellite and colorectal cancer risk.
    Gosse-Brun S; Sauvaigo S; Daver A; Larra F; Kwiatkowski F; Bignon YJ; Bernard-Gallon D
    Anticancer Res; 1998; 18(4A):2611-6. PubMed ID: 9703917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on Ha-ras RFLPs in gastric carcinoma and normal tissue DNAs of Chinese individuals].
    Shan X; Yan M; Huang Y; Mao Y; Wang S; Zhao S
    Yi Chuan Xue Bao; 1990; 17(2):154-60. PubMed ID: 1978686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.
    Domínguez G; Carballido J; Silva J; Silva JM; García JM; Menéndez J; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2002 Apr; 8(4):980-5. PubMed ID: 11948103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.